Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence
英夫利昔单抗治疗 III 级或 IV 级免疫检查点抑制剂肾炎的临床和转化证据
期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2025.10.018
Youssef, Nada; Habeeb, Masroor; Chen, Hong; Alhamal, Zainab; Mamlouk, Omar; Lin, Heather; Page, Valda; Tchakarov, Amanda; Basu, Sreyashi; Diab, Adi; Sharma, Padmanee; Abudayyeh, Ala